Podcasts about science europe

Bienvenidos a un nuevo episodio donde exploramos los límites de la ciencia, la ética y la biotecnología. Hoy tenemos el honor de hablar con Lluís Montoliu, una de las voces más respetadas en el campo de la genética y la bioética. Con más de tres décadas de experiencia, Lluís nos lleva a un viaje fascinante a través de su nuevo libro «No todo vale: ¿Qué hace un científico hablando de ética?», donde analiza los desafíos éticos que surgen en la investigación científica, especialmente en la edición genética con CRISPR. Desde los avances en organismos modificados genéticamente (OMG) hasta los dilemas éticos de la biología sintética, Lluís nos invita a reflexionar sobre el poder de la ciencia y la importancia de la bioética en la era moderna. Hablaremos de manera clara y accesible sobre cuestiones que nos afectan a todos: ¿Deberíamos preocuparnos por los alimentos transgénicos? ¿Qué significa realmente editar el ADN? ¿Cómo nos aseguramos de que la ciencia avance sin poner en riesgo nuestra salud o nuestros valores? Estas y otras preguntas serán el eje de nuestra conversación. Lluís Montoliu (Barcelona, 1963) es Licenciado y Doctor en Biología por la Universidad de Barcelona, investigador del Consejo Superior de Investigaciones Científicas (CSIC) y miembro del comité de dirección del Centro de Investigaciones Biomédicas en Red en Enfermedades Raras (CIBERER-Instituto de Salud Carlos III) en el Centro Nacional de Biotecnología en Madrid, del que actualmente es Vicedirector. Es el Director del nodo español del archivo europeo de ratones mutantes (EMMA/INFRAFRONTIER). Ha sido durante 20 años profesor honorario de la Universidad Autónoma de Madrid y es actualmente profesor honorífico de la Universidad Complutense de Madrid en la facultad de Biología. Ha trabajado en Barcelona, Heidelberg (Alemania) y Madrid. Lluís investiga sobre enfermedades raras, como el albinismo, usando modelos animales (ratones) modificados genéticamente con las herramientas CRISPR de edición genética, de cuyo uso fue pionero en España. Ha sido miembro y Presidente del Comité de Ética del CSIC y asesor de Presidencia del CSIC en temas de ética y de Science Europe. Forma parte del panel de ética del ERC en Bruselas. Ha fundado y presidido diversas sociedades científicas. Preside actualmente ESPCR, IFPCS y ARRIGE y es el Secretario Científico de la SEBBM. Ha escrito seis libros de divulgación científica sobre edición genética, dos sobre albinismo, genética de la pigmentación, enfermedades raras y bioética. Ha recibido diversos premios por sus investigaciones y por su intensa y extensa actividad divulgadora. ¡No te pierdas esta conversación única sobre los límites de la ciencia y la ética en la era de la biotecnología!

The Finnish Academy of Science and Letters has been active in the science-for-policy space in Finland for decades, including in recent years playing a leading role in setting up an important science advice mechanism for the Finnish government. Now it has also published a comprehensive handbook for researchers, with advice and practical exercises to help guide them in their first steps in policy engagement. In this episode, Linda Lammensalo talks to Toby Wardman about what's in the handbook and why. Resources mentioned in this episode Finnish academy handbook: https://acadsci.fi/en/publications/a-new-handbook-provides-tools-for-researchers-in-the-science-policy-interface/ Science Europe guidance: https://www.scienceeurope.org/our-resources/guidance-science-for-policy/ 

In recent months, there's been a small explosion of guidelines and handbooks on how to do science advice. In today's episode, Toby Wardman takes a deep dive into Science Europe's recent guidance for research-funding and research-performing organisations, in conversation with their author, Nicola Dotti.

Arutelus osalejad: Julia Rosend (Haridus- ja Teadusministeerium), prof. Art Leete (Tartu Ülikool), Rainer Saks (CybExer Technologies), Märt Volmer (Välisministeeriumi endine globaalteemade asekantsler, 31 aastase kogemusega diplomaat) Arutelujuht: Marten Juurik (teaduseetika valdkonna juht, Eesti Teadusagentuur) Arutelu korraldaja: Eesti Teadusagentuur 2021. aasta märtsis mõistis Harju maakohus vanglakaristuse Hiina sõjaväeluure kasuks töötanud Eesti mereteadlasele. See oli Eesti teadusele ühtaegu üllatav ja hoiatav ning vähendas teadlaste indu Hiinaga koostööd teha. Samal ajal on Euroopas teadust rahastavaid organisatsioone ühendav võrgustik Science Europe piiriülese koostöö osas otsimas lahendusi, kuidas võimaldada andmete jagamist ja teaduslikku koostööd Hiinaga. Teadlastele saadab see vastuolulisi signaale. Kui seni on üldiselt rahvusvahelist koostööd nähtud kui üdini positiivset suundumust, siis nüüd tuleb aina enam arvestada rahvusvahelise poliitika ja julgeoleku mõjudega. Samas puuduvad teadlastel vastavad kogemused ning pole ka selgeid suuniseid, millisel juhul kaaluvad julgeolekuhuvid üles teadusliku koostöö. Arutelu eesmärgiks on tõstatada küsimusi ja teadvustada probleeme seoses rahvusvahelise teaduskoostööga.

“The current world needs science, to develop well informed decisions. And that can only come from scientific autonomy.”“Scientific autonomy does not mean that individual scientists can or should be able to do whatever they want.”  In the second episode, Lidia Borrell-Damián (Secretary General of Science Europe) and Willem Halffman (Associate Professor at Radboud University) delve into the concept of scientific autonomy, addressing how it should be balanced with responsibility to avert ethical issues and dangers. 

Should politicians persecute scientists?  We explore the European Unions response to COVID and the vaccine rollout. We keep an eye on the UK's excellent progress whilst exploring 1984 themes today.We finish with a brief essay on the history of Soviet Russia and how we could be repeating the repressive mistakes of the past.Email: therealnormalpodcast@gmail.comTwitter: http://www.twitter.com/realnormalpod

Zougang zu wëssenschaftleche Publikatioune fir jiddereen. Resultater vun der ëffentlecher Fuerschung sollte fir all Mënsch zougänglech sinn. Ma d’Realitéit ass anescht:  D’Editiounshaiser verspäre wëssenschaftlech Publikatiounen hannert deiere Paywalls a maachen domadder enorm Beneficer. De Marc Schiltz steet als President vu Science Europe un der Spëtzt vun enger Initiative, déi des Paywalls wëll ofschafen (https://www.coalition-s.org/why-plan-s/).

Zougang zu wëssenschaftleche Publikatioune fir jiddereen. Resultater vun der ëffentlecher Fuerschung sollte fir all Mënsch zougänglech sinn. Ma d’Realitéit ass anescht:  D’Editiounshaiser verspäre wëssenschaftlech Publikatiounen hannert deiere Paywalls a maachen domadder enorm Beneficer. De Marc Schiltz steet als President vu Science Europe un der Spëtzt vun enger Initiative, déi des Paywalls wëll ofschafen (https://www.coalition-s.org/why-plan-s/).

Plan S, an initiative that requires participating research funders to immediately publish research in an open-access journal or repository, was announced in September 2018 by Science Europe with 11 participating agencies. Several others have signed on since the launch, but other funders and journal publishers have reservations. Host Meagan Cantwell speaks with Contributing Correspondent Tania Rabesandratana about those reservations and how Plan S is trying to change publishing practices and research culture at large. Some 1.7 million Jewish people were murdered by the Nazis in the 22 months of Operation Reinhard (1942–43) which aimed to eliminate all Jews in occupied Poland. But until now, the speed and totality of these murders were poorly understood. It turns out that about one-quarter of all Jews killed during the Holocaust were murdered in the autumn of 1942, during this operation. Meagan talks with Lewi Stone, a professor of biomathematics at Tel Aviv University in Israel and mathematical science at RMIT University in Melbourne, Australia, about this shocking kill rate, and why researchers are taking a quantitative approach to characterizing genocides. This week's episode was edited by Podigy. Download the transcript (PDF) Listen to previous podcasts. About the Science Podcast [Image: Michael Beckwith; Music: Jeffrey Cook]

Plan S, an initiative that requires participating research funders to immediately publish research in an open-access journal or repository, was announced in September 2018 by Science Europe with 11 participating agencies. Several others have signed on since the launch, but other funders and journal publishers have reservations. Host Meagan Cantwell speaks with Contributing Correspondent Tania Rabesandratana about those reservations and how Plan S is trying to change publishing practices and research culture at large. Some 1.7 million Jewish people were murdered by the Nazis in the 22 months of Operation Reinhard (1942–43) which aimed to eliminate all Jews in occupied Poland. But until now, the speed and totality of these murders were poorly understood. It turns out that about one-quarter of all Jews killed during the Holocaust were murdered in the autumn of 1942, during this operation. Meagan talks with Lewi Stone, a professor of biomathematics at Tel Aviv University in Israel and mathematical science at RMIT University in Melbourne, Australia, about this shocking kill rate, and why researchers are taking a quantitative approach to characterizing genocides. This week’s episode was edited by Podigy. Download the transcript (PDF) Listen to previous podcasts. About the Science Podcast [Image: Michael Beckwith; Music: Jeffrey Cook]

Welcome to the first episode of Technoculture!  My first guest is Michael Matlosz, Distinguished Professor of chemical engineering at the University of Lorraine and a member of the National Academy of Technologies of France. Former Director of the National School for Advanced Study of the Chemical Industries (ENSIC) in Nancy, he was Chairman and Chief Executive Officer of the French National Research Agency (ANR) in Paris from 2014 to 2017 and President of Science Europe in Brussels from 2015 to 2017, a non-profit organisation that brings together over forty research funding and research performing organisations from 27 European countries. In 2018, he was elected President of EuroScience, a non-profit association of researchers, teachers, journalists and other science professionals and interested citizens. Open to membership from individuals working in all scientific disciplines in Europe and throughout the world, EuroScience is committed to the advancement of research, science and innovation in Europe, thereby promoting the interests of its members. EuroScience currently has 2600 individual members from more than 70 countries. I met Michael at the headquarters of Science Europe in Brussels. It was a pleasure and an honour to speak to him. We discussed EuroScience, its mission and impact on the lives of every researcher and citizen in Europe, why it's important to join and to let your voice be heard. Check out more details at: http://technoculture-podcast.com/

Senior Communications Officer Martin Caudron discusses Europe’s move to make open access to publicly-funded scientific publications a reality by 2020, with Mary Kavanagh (Minister-Counselor for Science and Innovation at the EU Delegation to the U.S.), Robert-Jan Smits (European Commission’s Envoy for Open Access), Marc Schiltz (President of Science Europe and Chief Executive of Luxembourg National Research Fund), and David Sweeney (Executive Chair, Research England, UK Research and Innovation Agency).

Prateek Mahalwar is originally from India and completed his PhD under the supervision of Nobel laureate Prof. Christiane Nüsslein-Volhard at the Max Planck Institute for Developmental Biology in Tübingen, Germany. During this time, he studied the cellular mechanism of pigment pattern formation in zebrafish. Beside his PhD research, he was involved in several initiatives with Max Planck Society (MPG) stakeholders as the spokesperson and deputy spokesperson of the Max Planck PhDnet in 2015 and 2014 respectively. He has represented the MPG at several internal and external initiatives like Opencon (a global open science initiative), Early Career Researchers (ECR) advisory board member at eLife, science policy meetings with Science Europe and Open Access Ambassadors program at MPG. He has been an entrepreneur as well and co-founded two start-ups in parallel to his PhD studies. Currently, he is working as Manager Strategy - Life Sciences at Ernst & Young in Frankfurt. His work includes advising biotechnology, pharma and MedTech companies on investment, product commercialization and digitization topics.

The UK science community draws vital benefits from EU membership and could lose influence in the event of an exit, says a House of Lords report out this week. UK researchers placed a high value on collaboration opportunities afforded by EU membership. A number also believe the UK would lose its ability to influence EU science policy in the event of leaving - something that's disputed by pro-Brexit campaigners. To debate the ins and outs of being in or out of the EU, Adam is joined by Viscount Matt Ridley, a member of the committee, and Professor Paul Boyle, the Vice Chancellor of Leicester University and former president of Science Europe. Scientists at Aarhus University in Denmark are developing a quantum computer. To help them solve a particular problem, they have turned to human brain power, harnessing our ability to play computer games. The team have designed video games, such as Quantum Moves - that are helping them to understand the problem of 'slosh'- that atoms move about, when moved, like water sloshing in a cup. Many diseases are caused by a particular type of DNA error called a 'point mutation'. In our genomes, the substitution of a single letter of genetic code can be the root cause of diseases such as Alzheimer's, sickle cell anaemia, and a whole range of cancers. Recently, a new technique for editing DNA, called CRISPR, a precise genetic engineering tool, was developed, which might help combat these diseases. The problem is that the cell often reacts to this editing; trying to mend what it perceives as damage to its DNA. This week, David Liu, from Harvard University, published new research showing how his team have managed to switch out a single letter, a base pair, whilst tricking the cell into not correcting this edit.